Avricore Health Stock Analysis

Avricore Stock Analysis Notes

The company has price-to-book (P/B) ratio of 1.83. Some equities with similar Price to Book (P/B) outperform the market in the long run. Avricore Health last dividend was issued on the 21st of November 2016. The entity had 1:4 split on the 21st of November 2016. Avricore Health Inc. manufactures and sells over-the-counter products in Canada. Avricore Health Inc. was founded in 1996 and is headquartered in Vancouver, Canada. AVRICORE HEALTH operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on TSX Venture Exchange. For more info on Avricore Health please contact Hector Bremner at 604-773-8943 or go to https://avricore.com.

Avricore Health Investment Alerts

Avricore Health Thematic Classifications

Avricore Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avricore Health's market, we take the total number of its shares issued and multiply it by Avricore Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Avricore Profitablity

The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.13) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.13.

Management Efficiency

Avricore Health has return on total asset (ROA) of 0.039 % which means that it generated a profit of $0.039 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.048 %, meaning that it generated $0.048 on every $100 dollars invested by stockholders. Avricore Health's management efficiency ratios could be used to measure how well Avricore Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.34 in 2025. Return On Capital Employed is likely to drop to -0.33 in 2025. At this time, Avricore Health's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 2.1 M in 2025, whereas Other Current Assets are likely to drop slightly above 33 K in 2025.

Technical Drivers

As of the 20th of March, Avricore Health shows the Risk Adjusted Performance of (0.11), standard deviation of 6.18, and Mean Deviation of 4.2. Avricore Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Avricore Health value at risk, skewness, and the relationship between the maximum drawdown and potential upside to decide if Avricore Health is priced correctly, providing market reflects its regular price of 0.045 per share.

Avricore Health Price Movement Analysis

Avricore Health Outstanding Bonds

Avricore Health Predictive Daily Indicators

Avricore Health Forecast Models

Avricore Health's time-series forecasting models are one of many Avricore Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Avricore Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Avricore Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avricore shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Avricore Health. By using and applying Avricore Stock analysis, traders can create a robust methodology for identifying Avricore entry and exit points for their positions.

When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.